News 25 March

Victor Cervera-Carrascon published his second first-author paper. His review titled “Oncolytic Adenoviruses: a game changer approach in the battle between cancer and the immune system” was published in Expert Opinion […]



News 06-08 March

Spring symposium of Netherlands Society for Gene and Cell Therapy (NVGCT) celebrated 20th anniversary this year. For this special occasion, several prominent guest speakers were invited, including Len Seymour (Oxford […]



News 14-15 February

The third Cancer Center Amsterdam Retreat again took place at Hotel Noordwijk Conference Center Leeuwenhorst. Marta Lopez Gonzalez and Tereza Brachtlova both attended this conference, where many speakers gave relevant […]



News January

The Royal Dutch Cancer Society (KWF) awarded a grant in the KWF round 2018-II to prof. dr. Tanja de Gruijl for her research on “Selective tumor cell death and decreased immunosuppression by […]



VIRION at the SITC conference (Nov 2018)

VIRION team participated in the 33rd International Annual meeting and pre-conference of The Society for Immunotherapy of Cancer (SITC) in Washington, D.C. (USA). Marta Lopez Gonzalez presented her research work […]



Tereza Brachtlova publishes her first article in Cells (23 Nov 2018)

Tereza Brachtlova and Victor W van Beusechem published a review named “Unleashing the Full Potential of Oncolytic Adenoviruses against Cancer by Applying RNA Interference: The Force Awakens” in Cells. This […]



Register now for annual Biobusiness Summer School (Oct 2018)

Biobusiness Summer School 2019 will again be organized by VIRION partner Hyphen Projects. Testimonials from past participants, including Ioanna Milenova (class of 2017) and Victor Cervera-Carrascon and Joao Santos (class […]



Ioanna Milenova attends the Amsterdam Infection and Immunity Institute (AI&II) PhD retreat (24-26 Oct 2018)

Ioanna Milenova attended the Amsterdam Infection and Immunity Institute (AI&II) PhD retreat. She had an oral presentation, discussing the latest findings in combining an oncolytic virus with immune-modulatory molecules. The […]